Date Filed | Type | Description |
03/02/2022 |
4
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Paid exercise price by delivering 2,087 restricted stock units
@ $1.49, valued at
$3.1k
|
|
03/02/2022 |
4
| Korn Jerald (COO & General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Paid exercise price by delivering 2,046 restricted stock units
@ $1.49, valued at
$3k
|
|
01/18/2022 |
4
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 350,000 restricted stock units
@ $0 |
|
01/18/2022 |
4
| Long Alison S (Chief Medical Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 46,800 restricted stock units
@ $0 Granted 125,000 restricted stock units
@ $0 |
|
01/18/2022 |
4
| Korn Jerald (COO & General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 45,240 restricted stock units
@ $0 Granted 250,000 restricted stock units
@ $0 |
|
01/18/2022 |
4
| Duke William E. (CFO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 44,990 restricted stock units
@ $0 Granted 125,000 restricted stock units
@ $0 |
|
01/18/2022 |
4
| Menichella Daniel L (CEO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 70,200 restricted stock units
@ $0 Granted 250,000 restricted stock units
@ $0 |
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/02/2021 |
4
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 40,000 options to buy
@ $6.29, valued at
$251.6k
|
|
09/02/2021 |
4
| Korn Jerald (General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 100,000 options to buy
@ $6.29, valued at
$629k
|
|
09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Burnett Grady (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
07/01/2021 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Mixer Jean K (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
07/01/2021 |
4
| Prener Anne (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
07/01/2021 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
Granted 15,000 options to buy
@ $0 |
|
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| von Maltzahn Geoffrey (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
05/13/2021 |
3
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 3 on Kaleido Biosciences, Inc. |
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2021 |
4
| Korn Jerald (General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 60,000 options to buy
@ $9.81, valued at
$588.6k
|
|
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/01/2020 |
4
| von Maltzahn Geoffrey (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 15,000 options to buy
@ $7.43, valued at
$111.5k
|
|
07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|